Rocket Lab (NASDAQ: RKLB) has posted one-year revenue growth of 45.8%, cementing its place among the most compelling growth stories in the aerospace sector.
The company, which became the first private company in the Southern Hemisphere to reach space, offers rockets specifically designed for launching small satellites into orbit.
Rocket Lab has recorded annual revenue growth of 55.1% over the last two years, a figure that signals it is capturing meaningful market share during the current cycle.
Its operating margin expanded by 111.4 percentage points over the last five years as the business scaled and became significantly more efficient across its operations.
The company’s cash-burning tendencies have also improved over the same five-year period, raising the prospect that it could eventually reach full financial independence.
Rocket Lab shares are currently trading at $64.16, implying a forward price-to-sales multiple of 39.9x.
Halozyme Therapeutics (NASDAQ: HALO) is another standout, having delivered one-year revenue growth of 39.1% on the back of its proprietary ENHANZE drug-delivery platform.
The technology transforms hours-long intravenous infusions into minutes-long subcutaneous injections, a capability that has attracted strong licensing demand from pharmaceutical partners.
Halozyme has achieved annual revenue growth of 32.2% over the past two years while earnings per share grew at 28.7% annually over the last five years, outpacing many of its peers.
The company also generates impressive free cash flow, giving management the flexibility to fund new investments or return capital to shareholders through buybacks or dividends.
Halozyme shares are priced at $82.57, reflecting a forward price-to-earnings multiple of 9.4x, which positions the stock attractively relative to its growth profile.
Happen Bank (NYSE: HAPN), which pioneered peer-to-peer lending in the United States before evolving into a full digital banking platform, rounds out the trio with one-year revenue growth of 18.4%.
The bank operates a marketplace connecting borrowers with lenders and offers a suite of financial products including personal loans, auto refinancing, and broader banking services.
Happen Bank has sustained annual revenue growth of 18.1% over the past five years, a consistent record that suggests durable competitive positioning rather than a cyclical spike.
Earnings per share growth of 108% annually over the last two years significantly outpaced revenue expansion, reflecting strong operating leverage built into the business model.
Happen Bank shares trade at $19.10, representing a forward price-to-earnings multiple of 9.9x, a valuation that appears modest given the company’s demonstrated earnings momentum.
All three companies reflect the kind of durable, compounding growth characteristics that tend to reward long-term investors while weathering inevitable periods of broader market volatility.
